Transforming patient lives is core to our mission to deliver innovative treatments for rare, autoimmune diseases. We are proud of the research presented at this year’s European Academy of Neurology Congress and eager to continue expanding our patient reach. Discover more about our patient commitment: https://bit.ly/4cObzDG #TogetherWeDiscover #EAN2024
Excited to learn more about your groundbreaking research at EAN 2024! Your commitment to transforming lives through innovative treatments is truly commendable.
We attended these lectures and we were also proud that we, as a research team, are involved in research projects in which efgartigimod is administered to patients with MG. Congratulations Argenx 👏👏👏